The latest closing stock price for Leap Therapeutics as of July 02, 2025 is 0.29.
An investor who bought $1,000 worth of Leap Therapeutics stock at the IPO in 2017 would have $-996 today, roughly -1 times their original investment - a -50.40% compound annual growth rate over 8 years.
The all-time high Leap Therapeutics stock closing price was 100.10 on April 12, 2018.
The Leap Therapeutics 52-week high stock price is 4.79, which is 1551.7% above the current share price.
The Leap Therapeutics 52-week low stock price is 0.22, which is 24.1% below the current share price.
The average Leap Therapeutics stock price for the last 52 weeks is 1.73.
An investor who bought $1,000 worth of Leap Therapeutics stock at the IPO in 2017 would have $-996 today, roughly -1 times their original investment - a -50.40% compound annual growth rate over 8 years.
The all-time high Leap Therapeutics stock closing price was 100.10 on April 12, 2018.
The Leap Therapeutics 52-week high stock price is 4.79, which is 1551.7% above the current share price.
The Leap Therapeutics 52-week low stock price is 0.22, which is 24.1% below the current share price.
The average Leap Therapeutics stock price for the last 52 weeks is 1.73.